Please assess the completion status of the following clinical trial:

Trial Title: Hypertension in Hemodialysis Patients (Aim 3)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients on chronic hemodialysis for \> 3 mos.~2. Compliance with hemodialysis treatments as defined by less than one missed dialysis per month~3. Hypertension as diagnosed by ambulatory blood pressure monitoring (ABPM) \>135/75 mm Hg after participation in the ultrafiltration (UF) Trial, or those on no antihypertensive medications but unwilling to do UF Trial.~4. Presence of LVH on echocardiogram defined as left ventricular mass index (LVMi) \>104 g/m2 in women and \>116 g/m2 in men.~5. Willingness to give informed consent.~Exclusion criteria:~1. Vascular event (stroke, myocardial infarction or limb ischemia requiring bypass) within previous six months~2. Noncompliance with hemodialysis treatments~3. Known drug abuse~4. Chronic obstructive pulmonary disorder (COPD) requiring home oxygen~5. Congestive Heart Failure Class III or IV.~6. Body mass index \> 40 kg/m2.~7. Known contraindication to atenolol (severe heart failure, bradycardia, bronchial asthma, intolerance or allergy) or lisinopril (cough, pregnancy, intolerance or allergy)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Atenolol
- 2 (Type: EXPERIMENTAL): Lisinopril

Based on this trial design, predict the completion outcome and termination type (if applicable).